ImmunoGen, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ImmunoGen, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2022.
  • ImmunoGen, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.2M, a 14.3% decline year-over-year.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2022 was $5.3M, unchanged from 2021.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2021 was $5.3M, a 3.64% decline from 2020.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2020 was $5.5M, a 3.77% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $1.2M -$200K -14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q1 2021 $1.4M $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $1.4M +$100K +7.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q1 2019 $1.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.